Trump Backs Psychedelic Research for Mental Health

It's April 21st.

Welcome to El Paso News today, powered by AI.

President Trump just signed an executive order pushing for more research on psychedelics

like IvoGain to treat mental health problems.

This African plan-based drug shows promise against addiction, depression, and PTSD, and it's

a big national lift for studies already kicking off in.

Places like Texas.

Texas jumped ahead last summer when Governor Greg Abbott signed a bill letting the Health

Commission fund FDA clinical trials on these substances.

Then last month, they launched their own research program with $50 million from state funds.

Veterans are speaking out strong in support.

Folks like Air Force vet Eric Lionhart from Austin say similar treatments reveal their deepest

traumas and change their lives for the better, giving them real hope.

But challenges remain huge.

These drugs are still schedule one federally, meaning no accepted medical use, and the

FDA wants way more data before approvals.

Plus, experts warn about serious risks like heart issues, or worse, if not handled right

in medical settings.

With bets pushing hard and state stepping up, this could finally crack open better options

to fight suicide and heal minds nationwide.